Data / Form D filings / Capital Rx, Inc.
Capital Rx, Inc.: Form D filings
Capital Rx, Inc., a company in New York, NY, filed 7 Form D notices with the SEC between 2019 and 2025. The latest, on September 26, 2025, reports $230.8 million sold of a $232.9 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 228 PARK AVENUE S., SUITE 87234, New York, NY, 10003
- Phone
- (855) 538-8897
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1782959
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 26, 2025 | New notice | $232,885,143 | $230,820,898 | $2,064,245 | 8 | Aug 12, 2025 | sec.gov |
| Mar 22, 2024 | Amendment | $312,497,075 | $114,999,999 | $197,497,076 | 1 | Mar 6, 2024 | sec.gov |
| Mar 22, 2024 | New notice | $312,497,075 | $114,999,999 | $197,497,076 | 1 | Mar 6, 2024 | sec.gov |
| Jun 13, 2022 | New notice | $105,999,993 | $105,999,993 | 9 | May 27, 2022 | sec.gov | |
| Jul 14, 2021 | New notice | $3,480,430 | $3,480,430 | 4 | Apr 1, 2021 | sec.gov | |
| Jan 5, 2021 | New notice | $52,999,994 | $31,960,628 | $21,039,366 | 4 | Dec 21, 2020 | sec.gov |
| Jul 19, 2019 | New notice | $16,382,777 | $12,382,780 | $3,999,997 | 1 | Jul 2, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jared J. Kesselheim | Director | |
| Mark J. Kandrysawtz | Director | |
| Lenard J. Marcus | Director | |
| Ryan J. Kelly | Director | |
| Robert J. Mittendorff | Director | |
| Kevin J. Hill | Director | |
| Holly J. Maloney | Director | |
| Mostafa J. Kamal | Director | |
| A. J. Loiacono | Executive Officer, Director | |
| Daniel J. Delmastro | Director |
Other companies in New York that filed recently
- Padua High Ltd Liability Co offering · Oct 30, 2026
- BROWN, BROWN & BROWN, INC. $36,441 · Oct 30, 2026
- Apollo Infrastructure Co LLC $2.09 billion · Oct 29, 2026
- B&I TopCo, L.P. offering · Oct 28, 2026
- Adaptive Real Estate, Inc. $30 million · Oct 28, 2026
- RarePh8,Inc. $905,000 · Oct 27, 2026
Every Form D from the week of Sep 22, 2025 · All recent filings in New York · All recent Other filings
Read from SEC EDGAR. Amount sold is what Capital Rx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.